O Shaughnessy Asset Management LLC Increases Stake in The Clorox Company (NYSE:CLX)

O Shaughnessy Asset Management LLC grew its position in The Clorox Company (NYSE:CLXFree Report) by 10.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,829 shares of the company’s stock after acquiring an additional 1,980 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Clorox were worth $3,189,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CLX. Venturi Wealth Management LLC boosted its holdings in Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after purchasing an additional 145 shares in the last quarter. Northwest Financial Advisors acquired a new stake in shares of Clorox in the 4th quarter valued at approximately $29,000. Core Wealth Advisors Inc. purchased a new stake in shares of Clorox in the fourth quarter valued at approximately $29,000. First United Bank & Trust acquired a new position in Clorox during the fourth quarter worth $31,000. Finally, GoalVest Advisory LLC purchased a new position in Clorox in the first quarter worth $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on CLX. UBS Group lowered their price target on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. DA Davidson reiterated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. Barclays decreased their price target on Clorox from $132.00 to $122.00 and set an “underweight” rating on the stock in a research note on Friday, July 19th. Evercore ISI dropped their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday, May 1st. Finally, JPMorgan Chase & Co. decreased their target price on Clorox from $158.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday. Six analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $142.13.

View Our Latest Stock Analysis on CLX

Clorox Trading Up 0.2 %

Shares of Clorox stock traded up $0.24 during mid-day trading on Wednesday, hitting $132.80. 767,175 shares of the stock were exchanged, compared to its average volume of 1,232,006. The stock has a market capitalization of $16.49 billion, a price-to-earnings ratio of 68.81, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The company has a 50-day simple moving average of $133.91 and a 200 day simple moving average of $142.84.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the previous year, the company earned $1.51 EPS. Clorox’s revenue for the quarter was down 5.3% on a year-over-year basis. Research analysts forecast that The Clorox Company will post 5.92 EPS for the current year.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.